M&A Deal Summary |
|
|---|---|
| Date | 2011-09-19 |
| Target | Calypso Medical Technologies |
| Sector | Medical Products |
| Buyer(s) | Varian Medical Systems |
| Sellers(s) |
Bay City Capital
Nexus Life Science Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 10M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1948 |
| Sector | Medical Products |
| Revenue | 3.2B USD (2020) |
Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems was formed in 1948 and is based in Palo Alto, California.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 25 |
| Sector (Medical Products) | 2 of 9 |
| Type (Add-on Acquisition) | 7 of 22 |
| State (Washington) | 1 of 1 |
| Country (United States) | 4 of 13 |
| Year (2011) | 1 of 1 |
| Size (of disclosed) | 10 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-04-03 |
ACCEL Instruments
Bergisch Gladbach, Germany ACCEL Instruments GmbH is a supplier of proton therapy systems for cancer treatment and scientific research instruments. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-03-05 |
InfiMed
Liverpool, New York, United States InfiMed develops and supplies X-ray equipment manufacturers around the globe with specialized software and hardware for medical imaging applications, including radiography and fluoroscopy, digital radiography, cardiology and angiography. |
Buy | $15M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 34 of 62 |
| Sector (Medical Products) | 6 of 10 |
| Type (Add-on Acquisition) | 19 of 31 |
| State (Washington) | 4 of 4 |
| Country (United States) | 32 of 59 |
| Year (2011) | 2 of 3 |
| Size (of disclosed) | 18 of 18 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-02-02 |
Epocrates
San Mateo, California, United States Epocrates is a developer of medical application among U.S. physicians for clinical content, practice tools, and health industry engagement at the point of care. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-09-23 |
Aragon Surgical
Palo Alto, California, United States Aragon Surgical, Inc. is a manufacturers of surgical instruments and sterilization container systems. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Small |
| Type | Sector Focused |
Nexus Life Science Partners is a private equity firm that targets private and public healthcare companies located within the United States and around the world. The Firm's focus is on the growth segments of the healthcare industry. In particular, Nexus looks for product-driven life sciences companies developing breakthrough therapeutics for clinical needs, positively altering disease course and associated costs. The firm seeks for each private investment a potential for liquidity within 24 months after initial investment, as well as a 2-3 times return on invested capital. Nexus Life Science Partners was formed in 2001, and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 22 |
| Sector (Medical Products) | 3 of 3 |
| Type (Add-on Acquisition) | 9 of 10 |
| State (Washington) | 1 of 1 |
| Country (United States) | 16 of 19 |
| Year (2011) | 4 of 4 |
| Size (of disclosed) | 9 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-07 |
Salient Surgical Technologies
Portsmouth, New Hampshire, United States Salient Surgical provides devices that reduce surgical blood loss, reducing the need for transfusion. Utilizing Salient's saline-enhanced radio-frequency technology allows surgeons to control bleeding without charring and improve patient outcomes. Tissue is being sealed during liver resections, as well as orthopedic and spinal surgeries. |
Sell | $525M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-05-01 |
Aryx Therapeutics
Fremont, California, United States Aryx Therapeutics is a pharmaceutical company that uses retro-metabolic drug design to enhance drug safety, exploiting opportunities provided by the slow and/or toxic metabolism of top-selling drugs. Aryx Therapeutics was founded in 1997 and is based in Fremont, California. |
Sell | - |
